Park Ki, Bortnick Anna E, Lindley Kathryn J, Sintek Marc, Sethi Sanjum, Choi Calvin, Davis Melinda B, Walsh Mary N, Voeltz Michele, Bello Natalie A, Saw Jacqueline, Ahmed Mustafa M, Smilowitz Nathaniel R, Vidovich Mladen I
North Florida/South Georgia Veterans Health System, Malcom Randall VA Medical Center, Gainesville, Florida.
Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida.
J Soc Cardiovasc Angiogr Interv. 2022 Aug 7;1(5):100427. doi: 10.1016/j.jscai.2022.100427. eCollection 2022 Sep-Oct.
As the average maternal age advances with increasing concurrent cardiovascular disease risk factors, more women are entering pregnancy with or at risk for various cardiovascular conditions. Although rare, pregnant patients may require various cardiac interventions in the catheterization laboratory. An understanding of indications for intervention in pregnant patients with conditions such as myocardial infarction, severe valvular disease, and cardiogenic shock is critical to optimizing both fetal and maternal outcomes. This document highlights the most common cardiovascular conditions that may be encountered during pregnancy that may require intervention and highlights indications for intervention and periprocedural considerations to facilitate favorable maternal and fetal outcomes.
随着平均孕产妇年龄的增长以及同时存在的心血管疾病风险因素增加，越来越多的女性在怀孕时患有各种心血管疾病或有患病风险。尽管少见，但怀孕患者可能需要在导管实验室进行各种心脏干预。了解患有心肌梗死、严重瓣膜疾病和心源性休克等疾病的怀孕患者的干预指征，对于优化胎儿和母亲的结局至关重要。本文档重点介绍了怀孕期间可能遇到的、可能需要干预的最常见心血管疾病，并强调了干预指征和围手术期注意事项，以促进母婴获得良好结局。
